CIREX
Price
$82.60
Change
-$0.35 (-0.42%)
Updated
Jul 8 closing price
Net Assets
127.98B
FFARX
Price
$18.19
Change
-$0.03 (-0.16%)
Updated
Jul 8 closing price
Net Assets
2.94B
Interact to see
Advertisement

CIREX vs FFARX

CIREX vs FFARX Comparison Chart in %
View a ticker or compare two or three
VS
CIREX vs. FFARX commentary
Jul 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIREX is a Buy and FFARX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIREX has more cash in the bank: 128B vs. FFARX (2.94B). CIREX pays higher dividends than FFARX: CIREX (2.49) vs FFARX (1.35). CIREX was incepted earlier than FFARX: CIREX (24 years) vs FFARX (23 years). FFARX (1.27) is less costly to investors than CIREX (0.84). CIREX is a more actively managed with annual turnover of: 50.00 vs. FFARX (33.16). CIREX has a lower initial minimum investment than FFARX: CIREX (250) vs FFARX (1000). FFARX annual gain was more profitable for investors over the last year : 12.45 vs. CIREX (10.72). CIREX return over 5 years is better than : 39.65 vs. FFARX (34.77).
CIREXFFARXCIREX / FFARX
Total Expense Ratio0.841.2567%
Annual Report Gross Expense Ratio0.841.2766%
Fund Existence24 years23 years-
Gain YTD8.5026.633128%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets128B2.94B4,354%
Annual Yield % from dividends2.491.35185%
Returns for 1 year10.7212.4586%
Returns for 3 years42.0442.5399%
Returns for 5 years39.6534.77114%
Returns for 10 years90.3068.09133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JUEAX27.97N/A
N/A
JPMorgan US Equity A
GSMCX40.59N/A
N/A
Goldman Sachs Mid Cap Value Instl
GSRIX12.93N/A
N/A
Goldman Sachs Rising Dividend Gr Inv
AADBX15.50-0.12
-0.77%
American Beacon Balanced R5
CDEYX20.98-0.20
-0.94%
Columbia Intrinsic Value Institutional 3